期刊文献+

Impact of edaravone on serum CXC chemokine ligand-13 levels and perioperative neurocognitive disorders in elderly patients with hip replacement 被引量:3

原文传递
导出
摘要 Background:Perioperative neurocognitive disorders(PND)are a series of severe complications in the perioperative and anesthetic periods with a decline in memory,execution ability,and information processing speed as the primary clinical manifestation.This study aimed to evaluate the impact of edaravone(EDA)on PND and peripheral blood C-X-C motif chemokine ligand 13(CXCL13)levels in elderly patients with hip replacement.Methods:A total of 160 elderly patients undergoing hip arthroplasty in Affiliated Dongguan People’s Hospital of Southern Medical University(from March 2016 to March 2018)were randomly and double-blindly categorized into an EDA group and a control group(CON).Group EDA was administered intravenously EDA 30 min before surgery,and group CON was administered intravenously saline.The cognitive function of the two groups was evaluated 1-day before the operation and at 1 and 12 months after surgery,and the incidence of post-operative delirium was tested on days 1,3,and 7 after surgery using the Chinese version of the confusion assessment method.Serum CXCL13 and interleukin(IL)-6 concentrations were measured before anesthesia,during surgery(30 min after skin incision),and on days 1,3,and 7 after surgery.The continuous variables in accordance with normal distribution were tested using the Student’s t test,the continuous variables without normal distribution using the Mann-Whitney U test,and categorical variables by the x 2 test or Fisher exact test.Results:The incidence of post-operative delirium within 7 days after surgery was significantly higher in group CON than that in group EDA(31.3%vs.15.0%,t=-5.6,P<0.001).The modifiedtelephone interview for cognitive status andactivities of daily life scores were significantly higher in the group EDA than those in the group CON at 1 month(39.63±4.35 vs.33.63±5.81,t=-2.13,P<0.05and 74.3±12.6 vs.61.2±13.1,t=-1.69,P<0.05)and 12 months(40.13±5.93 vs.34.13±5.36,t=-3.37,P<0.05 and 79.6±11.7 vs.65.6±16.6,t=-2.08,P<0.05)after surgery;and the incidence of neurocognitive dysfunction was significantly lower in the group EDA than that in the group CON(P<0.05).Serum CXCL13 and IL-6 concentrations were significantly lower in the group EDA than those in the group CON during and after surgery(P<0.05).Conclusion:EDA can significantly reduce the serum concentrations of CXCL13 and IL-6 and improve the PND of patients.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第13期1610-1615,共6页 中华医学杂志(英文版)
基金 supported by the grant from the Projects of Guangdong Medical Science and Technology Research Foundation(No.C2018055).
  • 相关文献

参考文献1

二级参考文献15

  • 1C-ao L, Taha R, Gauvin D, et al. Postoperative cognitive dys-function after cardiac surgery. Chest, 2005, 12(8).. 3664-3667.
  • 2Cai L, Yi F, Dai Z, et al. Loss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS chal- lenge through excessive oxidative/nitra-tive stress. Am J Physiol Lung Cell Mol Physiol, 2014, 306(6).. 566-573.
  • 3Wang Y, Wang X, Lau WB, et al. Adiponectin inhibits tumor necrosis factor-a indueed vascular inflammatory re- sponse via caveolin-mediated ceramidaser recruitment and ac- tivation. Circ Res,2014, 114(5):792-805.
  • 4Teixeira AL, Diniz BS, Campos AC, et al. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Med, 2013, 15 (1) 115-121.
  • 5Zhang G, Sun Y, Wang Y, et al. Local administration of lac- tic acid and a low dose of the free radical scavenger, edara- vone, alleviates myocardial reperfusion injury in rats. J Card- iovasc Pharmacol, 2013,62 (4) .. 369-378.
  • 6Aarsland D, Muniz G, Matthews F. Nonlinear decline of mini-mental state examination in Parkinson's disease. Mov Disord,2011, 26(2) : 334-337.
  • 7Price CC, Garvan CW, Monk TG, et al. Type and severity of cognitive Decline in older adults after noncardiac surgery.Anesthesiology, 2008, 108(1) :8-17.
  • 8Aarsland D, Muniz G, Matthews F. Nonlinear decline of mini-mental state examination in Parkinson's disease. Mov Disord, 2011,26(2).. 334-337.
  • 9Psilopanagioti A, Papadaki H, Kranioti EF, et al. Expres- sion of adiponeetin and adiponectin receptors in human pituit- arygland and brain. Neuroendocrinology, 2009,89 (1) : 38-47.
  • 10Kamogawa K, Kohara K, Tabara Y, et al. Abdominal fat, adipose derived hormones and mild cognitive impairment., the J SHIPP study. Dement Geriatr Cogn Disord, 2010,30 (5): 432-439.

共引文献9

同被引文献25

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部